Workflow
Rocket Pharmaceuticals withdraws review application to FDA for RP-L102
Rocket PharmaceuticalsRocket Pharmaceuticals(US:RCKT) Seeking Alpha·2025-10-04 00:22

公司行动 - Rocket Pharmaceuticals自愿撤回其针对范可尼贫血的研究性基因疗法RP-L102在美国FDA的生物制品许可申请 [2]